# LUBIPROSTONE
> **ANDA214131** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2023-03-23
## Drug
- **FDA Application Number:** ANDA214131
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LUBIPROSTONE
- **Generic name:** LUBIPROSTONE
- **Active ingredients:** LUBIPROSTONE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS PHARMS
- **Manufacturer:** Zydus Pharmaceuticals USA Inc.
- **First approval:** 2023-03-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214131)
---
*AI Analytics · CC0 1.0*